A carregar...
MCLENA-1: A Phase II Clinical Trial for the Assessment of Safety, Tolerability, and Efficacy of Lenalidomide in Patients with Mild Cognitive Impairment Due to Alzheimer’s Disease
With the general population reaching higher ages, a surge in Alzheimer’s disease (AD) incidence will happen in the coming decades, putting a heavy burden on families and healthcare systems Worldwide. This emphasizes the pressing need for AD therapeutic interventions. Accumulating evidence indicates...
Na minha lista:
| Publicado no: | Open Access J Clin Trials |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7051033/ https://ncbi.nlm.nih.gov/pubmed/32123490 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/oajct.s221914 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|